BDX – BCAL Diagnostics Ltd


Subscribe for full access

Unlock Industry-grade Shariah Compliance for US, UK, Canada, Germany, GCC, Europe and India. See results from 5 major Shariah standards: AAOIFI, S&P, DJIM, FTSE and MSCI.

We provide unparalleled value and service.
Screened by AAOIFI Certified Shariah Advisor & Auditor.

Get started from just $3.99/month


1 = STRONG BUY | 2 = BUY | 3 = HOLD | 4 = UNDERPERFORM | 5 = SELL

Total Analysts: 0

Company Profile

BCAL Diagnostics Limited is an Australia-based screening and diagnostic company. The Company’s principal activities include developing a blood screening test to improve the early diagnosis and monitoring of breast cancer, including preparation for clinical trials, that is, of breast cancer, including preparation for clinical trials. The Company has developed a non-invasive laboratory blood test for the detection of breast cancer. The Company’s BCAL (Breast Cancer Associated Lipids test) test is a lipid biomarker blood test with the potential to be used for breast cancer prevention, screening, and monitoring. Its BCAL technology utilizes a single blood test on multiple levels: Disease detection, Diagnostic mass screening, and Post-intervention. The Company has partnered with integrated cancer care and cardiac provider GenesisCare to conduct clinical research required for regulatory approvals across several jurisdictions.

We do our best to screen stocks as accurately as possible. Please let us know in the comments if you spot an error or find something questionable. Jazaak Allahu khairan